Hogy Medical Co.,Ltd. Fundamental Analysis (JPX: 3593.T)
Hogy Medical Co.,Ltd. Fundamental Analysis (JPX: 3593.T)
Hogy Medical Co.,Ltd. (JPX: 3593.T) shows weak financial fundamentals with a PE ratio of 483.66, profit margin of 0.59%, and ROE of 0.30%. The company generates $37.8B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 55.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 3593.T's fundamental strength across five key dimensions:
Efficiency Score
Weak3593.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate3593.T shows balanced valuation metrics.
Growth Score
Moderate3593.T shows steady but slowing expansion.
Financial Health Score
Excellent3593.T maintains a strong and stable balance sheet.
Profitability Score
Moderate3593.T maintains healthy but balanced margins.
Key Financial Metrics
Is 3593.T Expensive or Cheap?
P/E Ratio
3593.T trades at 483.66 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 3593.T's PEG of -5.42 indicates potential undervaluation.
Price to Book
The market values Hogy Medical Co.,Ltd. at 1.93 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 19.11 times EBITDA. This signals the market has high growth expectations.
How Well Does 3593.T Make Money?
Net Profit Margin
For every $100 in sales, Hogy Medical Co.,Ltd. keeps $0.59 as profit after all expenses.
Operating Margin
Core operations generate 6.27 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.30 in profit for every $100 of shareholder equity.
ROA
Hogy Medical Co.,Ltd. generates $0.23 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Hogy Medical Co.,Ltd. produces operating cash flow of $5.86B, showing steady but balanced cash generation.
Free Cash Flow
Hogy Medical Co.,Ltd. generates weak or negative free cash flow of $398.00M, restricting financial flexibility.
FCF Per Share
Each share generates $18.46 in free cash annually.
FCF Yield
3593.T converts 0.28% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
483.66
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-5.42
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.93
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.79
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.16
vs 25 benchmark
Current Ratio
Current assets to current liabilities
5.34
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.003
vs 25 benchmark
ROA
Return on assets percentage
0.002
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How 3593.T Stacks Against Its Sector Peers
| Metric | 3593.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 483.66 | 32.13 | Worse (Expensive) |
| ROE | 0.30% | 552.00% | Weak |
| Net Margin | 0.59% | 30215.00% | Weak |
| Debt/Equity | 0.16 | 0.56 | Strong (Low Leverage) |
| Current Ratio | 5.34 | 5.70 | Strong Liquidity |
| ROA | 0.23% | 8.00% | Weak |
3593.T outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Hogy Medical Co.,Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation